About VEROVACCiNES
VEROVACCiNES is a company based in Halle (Germany) founded in 2017. VEROVACCiNES offers products and services including Subunit Vaccine Platform and Recombinant Yeast Strains. VEROVACCiNES operates in a competitive market with competitors including Merck Animal Health, TARGAN, Aptimmune Biologics, Indian Immunologicals and ViroVet, among others.
- Headquarter Halle, Germany
-
Sectors
HealthcareAgriculture
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eqmania Ug
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
GO-Bio
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VEROVACCiNES
VEROVACCiNES offers a comprehensive portfolio of products and services, including Subunit Vaccine Platform and Recombinant Yeast Strains.
Platform for rapid creation and optimization of animal vaccines using yeast strains.
Strains that express antigens for vaccine development in animal health.
Funding Insights of VEROVACCiNES
Investors in VEROVACCiNES
VEROVACCiNES has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include GO-Bio and High-Tech Gründerfonds.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Locked | Locked | Locked | |
|
Funding is provided for biotechnology research and innovation projects.
|
Locked | Locked | Locked |
Investor details for VEROVACCiNES
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by VEROVACCiNES
Investment portfolio details for VEROVACCiNES
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - VEROVACCiNES
Detailed financials for VEROVACCiNES
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Verovaccines Comparisons
Peer comparison for VEROVACCiNES
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of VEROVACCiNES
VEROVACCiNES operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck Animal Health, TARGAN, Aptimmune Biologics, Indian Immunologicals and ViroVet, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Vaccine technology is developed and supplied for livestock animals.
|
|
| Locked | Locked | Locked |
Automated targeted vaccine systems for livestock and aquaculture are developed.
|
|
| Locked | Locked | Locked |
Swine vaccines are developed using advanced mucosal technology.
|
|
| Locked | Locked | Locked |
Vaccines for animal and human health are manufactured.
|
|
| Locked | Locked | Locked |
Manufacturer and supplier of antiviral drugs for livestock
|
|
| Locked | Locked | Locked |
Offers patented immunostimulating vaccines for livestock.
|
Detailed competitors of VEROVACCiNES
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Verovaccines
Complete news archive for VEROVACCiNES
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about VEROVACCiNES
VEROVACCiNES was founded in 2017 and raised its 1st funding round 2 years after it was founded.
VEROVACCiNES is headquartered in Halle, Germany. It is registered at Halle, Sachsen-anhalt, Germany.
VEROVACCiNES was founded in 2017 in Halle, Germany, within the biotechnology sector focused on animal health. Novel vaccines are developed for treating infectious diseases in animals, utilizing recombinant strains of the yeast Kluyveromyces lactis. Antigens are expressed by these strains to target various pathogens. Operations center on research and production of these specialized immunizations, with a presence maintained through the domain verovaccines.com.
VEROVACCiNES's top competitors include TARGAN, Merck Animal Health and Indian Immunologicals.
VEROVACCiNES offers Subunit Vaccine Platform and Recombinant Yeast Strains.
VEROVACCiNES has 2 investors. Key investors include GO-Bio, and High-Tech Gründerfonds.